Total Reports
8,853
FDA CVM filings
Dog /
FDA CVM · 2025 release 8,853 reports on file
Spitz - German Pomeranian - FDA Adverse Event Profile
Adverse-event records for Spitz - German Pomeranian (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Spitz - German Pomeranian ranks #23 by report volume among dog breeds - 439 of 8,853 reports (5.0%) recorded a death outcome.
- #23
- most-reported dog breed
- 5.0%
- death-coded report share
- 2,084
- Vomiting - top reaction
- 5.9 yr
- average age at report
Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.
Deaths Reported
439
of 8,853 reports
Death Rate
5.0%
death-coded share
Avg Age at Report
5.9 yr
5.2 kg avg weight
Death-Coded Outcome Share
Spitz - German Pomeranian death-coded reports 5.0%
Cross-breed median
5.0% of 8,853 spitz - german pomeranian reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 5.2 kg (11.5 lbs)
Top Reported Reactions
Vomiting 2,084
Lethargy (see also Central nervous system depression in 'Neurological') 1,072
Lack of efficacy (ectoparasite) - flea 963
Emesis 929
Diarrhoea 676
Seizure NOS 534
Anorexia 385
Lack of efficacy - NOS 368
Death 276
Behavioural disorder NOS 262
Ataxia 258
Lack of efficacy (endoparasite) - hookworm 244
Shaking 236
Not eating 232
Emesis (multiple) 230
Most Referenced Drugs
Milbemycin Oxime + Spinosad 1,770
Spinosad 1,240
Afoxolaner 565
Ivermectin + Pyrantel As Pamoate Salt 495
Fluralaner Chew Tablets 411
Pyrantel Pamoate;Sarolaner 411
Moxidectin 346
Fluralaner 13.64% 12-Week Chew 303
Nitenpyram 254
Selamectin 211
Milbemycin Oxime + Praziquantel 208
Sarolaner 203
Imidacloprid + Moxidectin 175
Maropitant Citrate 155
Oclacitinib Maleate 141
Outcome Breakdown
Recovered/Normal
3,173 (38.9%)
Outcome Unknown
2,527 (31.0%)
Ongoing
1,696 (20.8%)
Recovered with Sequela
325 (4.0%)
Died
308 (3.8%)
Euthanized
131 (1.6%)
Gender Distribution
Male 4,463 (50.4%)
Female 4,159 (47.0%)
Unknown 200 (2.3%)
Mixed 31 (0.4%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 387 | |
| 2011 | 510 | |
| 2012 | 766 | |
| 2013 | 785 | |
| 2014 | 759 | |
| 2015 | 691 | |
| 2016 | 661 | |
| 2017 | 680 | |
| 2018 | 576 | |
| 2019 | 555 | |
| 2020 | 455 | |
| 2021 | 455 | |
| 2022 | 374 | |
| 2023 | 408 | |
| 2024 | 479 | |
| 2025 | 312 | |
Spitz - German Pomeranian Pet Health Insights
Spitz - German Pomeranian accounts for 8,853 FDA adverse event reports, ranking #23 by volume among dog breeds, with 439 reports (5.0%) coded as a death outcome. Mean age at report: 5.9 years, average weight 5.2 kg (11.5 lbs).
Top reported signs: Vomiting (2,084), Lethargy (see also Central nervous system depression in 'Neurological') (1,072), Lack of efficacy (ectoparasite) - flea (963). Most-referenced drug: Milbemycin Oxime + Spinosad (1,770 reports), followed by Spinosad (1,240) and Afoxolaner (565).
Outcome coding on 8,160 status-recorded reports is dominated by Recovered/Normal (38.9%). Annual submissions ranged 2,010-2,025 across 16 years on file.
Dog Breeds With a Similar Report Volume
Pug
9,020 reports · 5.1% death rate
Siberian Husky
9,399 reports · 4.4% death rate
Terrier - Bull - American Pit
8,232 reports · 4.5% death rate
Collie - Border
9,801 reports · 4.3% death rate
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)
7,541 reports · 3.6% death rate
Spaniel - Cocker American
7,534 reports · 4.0% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Spitz - German Pomeranian? ▼
There are 8,853 adverse event reports involving Spitz - German Pomeranian in the FDA database, with 439 reports involving death (5.0% death rate). Spitz - German Pomeranian ranks #23 by report volume.
What are the most common adverse reactions reported for Spitz - German Pomeranian? ▼
The most commonly reported adverse reactions for Spitz - German Pomeranian are Vomiting (2,084 reports), Lethargy (see also Central nervous system depression in 'Neurological') (1,072 reports), Lack of efficacy (ectoparasite) - flea (963 reports), Emesis (929 reports), Diarrhoea (676 reports).
What drugs are most frequently associated with Spitz - German Pomeranian adverse events? ▼
The drugs most frequently referenced in Spitz - German Pomeranian adverse event reports are Milbemycin Oxime + Spinosad (1,770 reports), Spinosad (1,240 reports), Afoxolaner (565 reports), Ivermectin + Pyrantel As Pamoate Salt (495 reports), Fluralaner Chew Tablets (411 reports).
What is the average age of Spitz - German Pomeranian in adverse event reports? ▼
The average age of Spitz - German Pomeranian at the time of adverse event reports is 5.9 years, with an average weight of 5.2 kg (11.5 lbs).
Does a high number of adverse event reports mean Spitz - German Pomeranian is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Spitz - German Pomeranian safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.